Summary:
The study is involving an investigational medication for diabetics who are already on metformin. The study will last 27 weeks with 16 site visits.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have been diagnosed with Diabetes for at least 3 months
•
Have been on a stable dose of Metformin for at least 3 months
Qualified Participants May Receive:
The study product, clinic and phone visits, laboratory work, and study-related care at no cost.